1. 疾病领域
  2. 癌症 泌尿生殖系统疾病
  3. 前列腺癌 泌尿生殖系统癌症
  4. PSMA-1-DOTA

PSMA-1-DOTA 是一种高亲和力的前列腺特异性膜抗原 (PSMA) 结合剂,可实现用于成像与治疗的靶向放射性核素递送。PSMA-1-DOTA 可作为肿瘤生长抑制剂,能够抑制表达 PSMA 的前列腺肿瘤的生长。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

PSMA-1-DOTA

PSMA-1-DOTA Chemical Structure

CAS No. : 3024672-17-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PSMA-1-DOTA is a prostate-specific membrane antigen (PSMA) binder with high affinity, enables targeted radionuclide delivery for imaging and therapy. PSMA-1-DOTA acts as a tumor growth inhibitor that reduces growth of PSMA-expressing prostate cancer tumors[1].

体外研究
(In Vitro)

PSMA-1-DOTA (1 h) 可抑制 ³H-ZJ24 与 PC3pip 细胞的结合,其 IC50 为 1.83 nM,对 PSMA 的亲和力约为 PSMA-I&T 和 PSMA-11 的 4 倍[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

PSMA-1-DOTA (1.4 mg/kg;i.v.;单剂量) 在NMRI小鼠中耐受性良好,仅在淋巴组织中出现轻微的组织病理学改变[1]
[177Lu]Lu-PSMA-1-DOTA (总剂量 111 MBq,2 天内分 4 次给药,每次 27.75 MBq;或 111 MBq 单剂量;静脉注射) 可有效抑制 PC3pip 异种移植小鼠的肿瘤生长达 24 天[1]
[68Ga]Ga-PSMA-1-DOTA (7.4 MBq;静脉注射) 在异种移植小鼠体内可靶向 PC3pip 肿瘤,同时在肾脏和唾液腺中的非靶标摄取量极低[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: athymic nude [Foxn1/nu/Foxn1/nu] (male, 6-8 weeks old, PC3pip subcutaneous xenograft model)[1]
Dosage: 111 MBq (3 mCi) total, 4 doses of 27.75 MBq each over 2 days; 111 MBq (3 mCi) single dose
Administration: i.v.; 4 doses over 2 days (day 0); single dose (day 13)
Result: Eliminated tumor growth for 24 days; achieved tumor inhibitory activity comparable to [¹⁷⁷Lu]Lu-PSMA-617 (positive control).
Animal Model: athymic nude [Foxn1/nu/Foxn1/nu] (male, PC3pip subcutaneous xenograft model)[1]
Dosage: 7.4 MBq (200 μCi)
Administration: i.v.
Result: Showed significantly lower kidney and salivary gland uptake compared to [⁶⁸Ga]Ga-PSMA-11 and [⁶⁸Ga]Ga-PSMA I&T; reached tumor-to-left salivary gland ratio of 13.45 at 30 minutes and 27.43 at 1 hour post-injection.
Animal Model: NMRI (male, 8 weeks old)[1]
Dosage: 1.4 mg/kg
Administration: i.v.; single dose
Result: Observed no mortality, significant body weight changes, or abnormal clinical signs; detected no significant changes in clinical chemistry parameters on day 2 or day 15; identified test item-related histopathological changes in spleen, bone marrow, and inguinal lymph nodes (present after 14-day recovery).
分子量

1473.54

Formula

C62H100N14O27

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
PSMA-1-DOTA
目录号:
HY-185167
需求量: